TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06911632: Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Sponsor: Tempus AI · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 900 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$398,400

Rescue Site Savings

+$265,600

Unlock Full NCT06911632 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06911632 Rescue Dossier →